Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma.
MedStar author(s):Citation: Clinical lymphoma, myeloma & leukemia. 21(2):e185-e193, 2021 02.PMID: 33132102Institution: MedStar Health Research Institute | MedStar Heart & Vascular Institute | MedStar Washington Hospital Center | Washington Cancer Institute | Washington Cancer Institute HDepartment: Medicine/Infectious Diseases | Medicine/Internal MedicineForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Antiviral Agents/tu [Therapeutic Use] | *Hepacivirus/ip [Isolation & Purification] | *Hepatitis C/dt [Drug Therapy] | *Lymphoma, Non-Hodgkin/mo [Mortality] | Adolescent | Adult | Aged | Aged, 80 and over | Female | Hepacivirus/ge [Genetics] | Hepatitis C/vi [Virology] | Humans | Lymphoma, Non-Hodgkin/th [Therapy] | Lymphoma, Non-Hodgkin/vi [Virology] | Male | Middle Aged | Progression-Free Survival | Retrospective Studies | RNA, Viral/ip [Isolation & Purification] | Young AdultYear: 2021ISSN:
- 2152-2669
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 33132102 | Available | 33132102 |
BACKGROUND: Improved hepatitis C virus (HCV) clearance due to directly acting antiviral agents has led to remarkably improved outcomes of indolent HCV-associated non-Hodgkin lymphoma (NHL). The impact of directly acting antivirals on the outcomes of aggressive NHL is still under investigation. Characteristics of HCV-associated NHL in black patients are not well characterized. We report outcomes of HCV-associated NHL compared to their HCV-negative counterparts in a predominantly black population.
CONCLUSION: HCV clearance is positively associated with lymphoma outcomes in black patients. Patients who clear HCV have noninferior outcomes to HCV- patients, while those who fail to clear HCV have significantly worse outcomes. Copyright (c) 2020 Elsevier Inc. All rights reserved.
PATIENTS AND METHODS: Patients with lymphoma between January 2007 and December 2017 were retrospectively studied. Depending on presence or absence of HCV RNA, patients were grouped into HCV positive (HCV+) and HCV negative (HCV-) cohorts. Depending on virologic clearance (VC), HCV+ were classified into HCV+ with VC and HCV+ without VC. Overall response rate (ORR), complete response, overall survival (OS), and progression-free survival (PFS) of HCV+ patients with and without VC were compared to HCV- patients.
RESULTS: Of 397 patients with lymphoma, 40 had HCV. Black comprised 90% of HCV+ patients. Diffuse large B-cell lymphoma was most frequent (47%) in the HCV+ group. HCV+ patients without VC had significantly worse OS and PFS compared to HCV- patients. There were no differences in ORR, complete response, PFS, and OS of HCV+ patients with VC and HCV- patients. These results were consistent in subgroups of diffuse large B-cell lymphoma and aggressive lymphoma.
English
-
1
Cardiovascular Disease in Older Women. [Review]
-
2
Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population.
-
3
Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population.
-
4
Cardiovascular risk among ultra-endurance runners.
-
5
Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity. [Review]
-
6
Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study.
-
7
Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study.
-
8
Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
-
9
Lipid-related markers and cardiovascular disease prediction.
-
10
Relation of Absence of Coronary Artery Calcium to Cardiovascular Disease Mortality Risk Among Individuals Meeting Criteria for Statin Therapy According to the 2018/2019 ACC/AHA Guidelines.
-
11
Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study.
-
12
Cardiovascular Disease After Aromatase Inhibitor Use.
-
13
Trends in Cardiovascular Disease Morbidity and Mortality in American Indians Over 25 Years: The Strong Heart Study.
-
14
Cardiac care for older adults. Time for a new paradigm.
-
15
Both Light Intensity and Moderate-to-Vigorous Physical Activity Measured by Accelerometry Are Favorably Associated With Cardiometabolic Risk Factors in Older Women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study.
-
16
Perceived social support and the risk of cardiovascular disease and all-cause mortality in the Women's Health Initiative Observational Study.
-
17
Associations between incident ischemic stroke events and stroke and cardiovascular disease-related genome-wide association studies single nucleotide polymorphisms in the Population Architecture Using Genomics and Epidemiology study.
-
18
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.
-
19
Joint association of nicotinic acetylcholine receptor variants with abdominal obesity in American Indians: the Strong Heart Family Study.
-
20
Editorial: Levothyroxine Therapy in Patients With Hypothyroidism.
-
21
Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study.
-
22
All-cause, cardiovascular, and cancer mortality in western Alaska Native people: western Alaska Tribal Collaborative for Health (WATCH).
-
23
Social Determinants of Suboptimal Cardiovascular Health Among Pregnant Women in the United States.
-
24
Relation of Pregnancy Loss to Risk of Cardiovascular Disease in Parous Postmenopausal Women (From the Women's Health Initiative).
-
25
Fatty acids linked to cardiovascular mortality are associated with risk factors.
-
26
Association of Major Dietary Protein Sources With All-Cause and Cause-Specific Mortality: Prospective Cohort Study.
-
27
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review.
-
28
Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: the Strong Heart Study.
-
29
Vaccination Serology Status and Cardiovascular Mortality: Insight from NHANES III and Continuous NHANES.
-
30
Pre-Operative Cardiovascular Testing and Post-Renal Transplant Clinical Outcomes.
-
31
The association of mannose binding lectin genotype and immune response to Chlamydia pneumoniae: The Strong Heart Study.
-
32
Lipoprotein-associated phospholipase A(2) mass and activity and risk of cardiovascular disease in a population with high prevalences of obesity and diabetes: the Strong Heart Study.
-
33
Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy.
-
34
Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study.[Summary for patients in Ann Intern Med. 2013 Nov 19;159(10):I-20; PMID: 24400335]
-
35
Ambulatory Activity and Risk of Premature Mortality Among Young and Middle-aged American Indian Individuals.
-
36
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.
-
37
Cadmium exposure and incident cardiovascular disease.
-
38
C-reactive protein, fibrinogen, and cardiovascular disease prediction.
-
39
Kidney Function and Cardiovascular Events in Postmenopausal Women: The Impact of Race and Ethnicity in the Women's Health Initiative.
-
40
Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study.
-
41
Smoking-attributable mortality in American Indians: findings from the Strong Heart Study.
-
42
Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes.
-
43
Serum lipid concentrations among persons with spinal cord injury - a systematic review and meta-analysis of the literature. [Review]
-
44
The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review.
-
45
Cardiovascular Disease in American Indian and Alaska Native Youth: Unique Risk Factors and Areas of Scholarly Need.
-
46
Cardiovascular risk stratification among individuals with obesity: The Coronary Artery Calcium Consortium.
-
47
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
-
48
Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease.
-
49
Cardiovascular risk stratification among individuals with obesity: The Coronary Artery Calcium Consortium.
-
50
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
-
51
Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study.
-
52
Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program.
-
53
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.
-
54
Role of Critical Care Medicine Training in the Cardiovascular Intensive Care Unit: Survey Responses From Dual Certified Critical Care Cardiologists.
-
55
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives. [Review]
-
56
Risk and Causes of Death among Former National Football League Players (1986-2012).
-
57
Peroral endoscopic myotomy for management of cricopharyngeal bars (CP-POEM): a retrospective evaluation.
-
58
Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry.
-
59
Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study.
-
60
Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study.
-
61
The perimenopausal atherosclerosis transition: relationships between calcified and noncalcified coronary, aortic, and carotid atherosclerosis and risk factors and hormone levels.
-
62
Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?.
-
63
All-cause, cardiovascular, and cancer mortality rates in postmenopausal white, black, Hispanic, and Asian women with and without diabetes in the United States: the Women's Health Initiative, 1993-2009.
-
64
Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility.
-
65
Left Ventricular Mass, Brain Magnetic Resonance Imaging, and Cognitive Performance: Results From the Strong Heart Study.
-
66
Mean HEART scores for hospitalized chest pain patients are higher in more experienced providers.
-
67
Association of low-moderate urine arsenic and QT interval: Cross-sectional and longitudinal evidence from the Strong Heart Study.
-
68
Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement.
-
69
Arsenic metabolism and one-carbon metabolism at low-moderate arsenic exposure: Evidence from the Strong Heart Study.
-
70
Circulating Sphingolipids, Insulin, HOMA-IR and HOMA-B: the Strong Heart Family Study.
-
71
Intravascular ultrasound evidence of perivascular trauma during routine percutaneous coronary intervention.
-
72
Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.
-
73
The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy.
-
74
Utilizing harmonization and common surveillance methods to consolidate 4 cohorts: the Western Alaska Tribal Collaborative for Health (WATCH) study.
-
75
Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.
-
76
Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging.
-
77
Processed Meat, but Not Unprocessed Red Meat, Is Inversely Associated with Leukocyte Telomere Length in the Strong Heart Family Study.
-
78
Leukocyte telomere length and ideal cardiovascular health in American Indians: the Strong Heart Family Study.
-
79
Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women.
-
80
Cardiovascular risk and communication among early stage breast cancer survivors.
-
81
Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
-
82
Comparison of Correlated Comorbidities in Male and Female Sexual Dysfunction: Findings From the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).
-
83
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
-
84
Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States.
-
85
In-Stent Restenosis of Drug-Eluting Stents Compared With a Matched Group of Patients With De Novo Coronary Artery Stenosis.
-
86
Sex differences in obesity prevalence and cardiometabolic factors among Western Alaska Native people.
-
87
Dietary patterns and their association with cardiovascular risk factors in a population undergoing lifestyle 130224s: The Strong Heart Study.
-
88
Associations of Age and Sex With Marfan Phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry.
-
89
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma.
-
90
Association between comorbidities and female sexual dysfunction: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).
-
91
Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study.
-
92
Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
-
93
Pre-Operative Cardiovascular Testing before Liver Transplantation.
-
94
The impact of intracoronary thrombus aspiration on STEMI outcomes.
-
95
Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis.